Nath LR - Search Results

1

Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma.

Swetha M, Keerthana CK, Rayginia TP, Nath LR, Haritha NH, Shabna A, Kalimuthu K, Thangarasu AK, Aiswarya SU, Jannet S, Pillai S, Harikumar KB, Sundaram S, Anto NP, Wu DH, Lankalapalli RS, Towner R, Isakov N, Deepa SS, Anto RJ. Swetha M, et al. Among authors: nath lr. Pharmaceuticals (Basel). 2022 May 22;15(5):636. doi: 10.3390/ph15050636. Pharmaceuticals (Basel). 2022. PMID: 35631464 Free PMC article.

2

Cytotoxicity studies of semi-synthetic derivatives of theveside derived from the aqueous extract of leaves of 'suicide tree' Cerbera odollam.

Gorantla JN, Vellekkatt J, Nath LR, Anto RJ, Lankalapalli RS. Gorantla JN, et al. Among authors: nath lr. Nat Prod Res. 2014;28(18):1507-12. doi: 10.1080/14786419.2014.913242. Epub 2014 May 8. Nat Prod Res. 2014. PMID: 24805359

3

[6]-Gingerol induces caspase-dependent apoptosis and prevents PMA-induced proliferation in colon cancer cells by inhibiting MAPK/AP-1 signaling.

Radhakrishnan EK, Bava SV, Narayanan SS, Nath LR, Thulasidasan AK, Soniya EV, Anto RJ. Radhakrishnan EK, et al. Among authors: nath lr. PLoS One. 2014 Aug 26;9(8):e104401. doi: 10.1371/journal.pone.0104401. eCollection 2014. PLoS One. 2014. PMID: 25157570 Free PMC article.

4

DW-F5: A novel formulation against malignant melanoma from Wrightia tinctoria.

Antony J, Saikia M, Vinod V, Nath LR, Katiki MR, Murty MS, Paul A, Shabna A, Chandran H, Joseph SM, Nishanth KS, Panakkal EJ, Sriramya I, Sridivya I, Ran S, Sankar S, Rajan E, Anto RJ. Antony J, et al. Among authors: nath lr. Sci Rep. 2015 Jun 10;5:11107. doi: 10.1038/srep11107. Sci Rep. 2015. PMID: 26061820 Free PMC article.

5

In Vitro Evaluation of the Antioxidant, 3,5-Dihydroxy-4-ethyl-trans-stilbene (DETS) Isolated from Bacillus cereus as a Potent Candidate against Malignant Melanoma.

Nath LR, Kumar SN, Das AA, Nambisan B, Shabna A, Mohandas C, Anto RJ. Nath LR, et al. Front Microbiol. 2016 Apr 14;7:452. doi: 10.3389/fmicb.2016.00452. eCollection 2016. Front Microbiol. 2016. PMID: 27148169 Free PMC article.

6

Evaluation of uttroside B, a saponin from Solanum nigrum Linn, as a promising chemotherapeutic agent against hepatocellular carcinoma.

Nath LR, Gorantla JN, Thulasidasan AK, Vijayakurup V, Shah S, Anwer S, Joseph SM, Antony J, Veena KS, Sundaram S, Marelli UK, Lankalapalli RS, Anto RJ. Nath LR, et al. Sci Rep. 2016 Nov 3;6:36318. doi: 10.1038/srep36318. Sci Rep. 2016. PMID: 27808117 Free PMC article.

7

Kaempferol-Mediated Sensitization Enhances Chemotherapeutic Efficacy of Sorafenib Against Hepatocellular Carcinoma: An In Silico and In Vitro Approach.

Nair B, Anto RJ, M S, Nath LR. Nair B, et al. Among authors: nath lr. Adv Pharm Bull. 2020 Jul;10(3):472-476. doi: 10.34172/apb.2020.058. Epub 2020 May 11. Adv Pharm Bull. 2020. PMID: 32665908 Free PMC article.

8

Author Correction: Evaluation of uttroside B, a saponin from Solanum nigrum Linn, as a promising chemotherapeutic agent against hepatocellular carcinoma.

Nath LR, Gorantla JN, Thulasidasan AKT, Vijayakurup V, Shah S, Anwer S, Joseph SM, Antony J, Veena KS, Sundaram S, Marelli UK, Lankalapalli RS, Anto RJ. Nath LR, et al. Sci Rep. 2020 Nov 18;10(1):20431. doi: 10.1038/s41598-020-77440-0. Sci Rep. 2020. PMID: 33208836 Free PMC article.

9

Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma.

Devan AR, Kumar AR, Nair B, Anto NP, Muraleedharan A, Mathew B, Kim H, Nath LR. Devan AR, et al. Among authors: nath lr. Pharmaceuticals (Basel). 2021 Jul 9;14(7):656. doi: 10.3390/ph14070656. Pharmaceuticals (Basel). 2021. PMID: 34358082 Free PMC article. Review.

10

Blockade of Uttroside B-Induced Autophagic Pro-Survival Signals Augments Its Chemotherapeutic Efficacy Against Hepatocellular Carcinoma.

Nath LR, Swetha M, Vijayakurup V, Thangarasu AK, Haritha NH, Shabna A, Aiswarya SU, Rayginia TP, Keerthana CK, Kalimuthu K, Sundaram S, Lankalapalli RS, Pillai S, Towner R, Isakov N, Anto RJ. Nath LR, et al. Front Oncol. 2022 Feb 8;12:812598. doi: 10.3389/fonc.2022.812598. eCollection 2022. Front Oncol. 2022. PMID: 35211405 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page